Management of eight cases of subarachnoid hemorrhage using transpulmonary thermodilution during clazosentan therapy
Clazosentan, an endothelin receptor antagonist, is used to prevent delayed neurological deterioration in patients with subarachnoid hemorrhage due to ruptured cerebral aneurysms. However, fluid management presents challenges. This single-center case series presents the findings from eight patients u...
Saved in:
Main Authors: | Hiroto Iyota, Yasumasa Kawano, Hironori Fukumoto, Takato Tajiri, Mitsutoshi Iwaasa, Sinichi Morimoto, Yoshito Izutani, Shintaro Yamasaki, Kazuya Yamauchi, Hiroki Hatomoto, Hiroshi Abe, Yoshihiko Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Interdisciplinary Neurosurgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221475192500009X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Clazosentan on Vasospasm Reduction and Functional Recovery after Aneurysmal Subarachnoid Hemorrhage
by: Sosho KAJIWARA, et al.
Published: (2025-01-01) -
Approaches and applications in transdermal and transpulmonary gene drug delivery
by: Anni Zhang, et al.
Published: (2025-01-01) -
Comparison of airway pressure release ventilation (APRV) versus biphasic positive airway pressure (BIPAP) ventilation in COVID-19 associated ARDS using transpulmonary pressure monitoring
by: Sandra Emily Stoll, et al.
Published: (2025-02-01) -
How to Reliably Measure Stroke Volume Index in Pulmonary Arterial Hypertension: A Comparison of Thermodilution, Direct and Indirect Fick, and Cardiac MRI
by: Andrea Baccelli, et al.
Published: (2025-01-01) -
Why do we use transpulmonary thermodilution and pulmonary artery catheter in severe shock patients?
by: Xavier Monnet, et al.
Published: (2025-01-01)